MULTIPLE PHENOTYPIC DIVERGENCE OF MAMMARY ADENOCARCINOMA CELL CLONES .2. SENSITIVITY TO RADIATION, HYPERTHERMIA AND FUDR

被引：26

作者：

WELCH, DR

EVANS, DP

TOMASOVIC, SP

MILAS, L

NICOLSON, GL

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT TUMOR BIOL,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT EXPTL RADIOTHERAPY,HOUSTON,TX 77030

[3] UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77025

来源：

CLINICAL & EXPERIMENTAL METASTASIS | 1984年 / 2卷 / 04期

关键词：

D O I：

10.1007/BF00135173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：357 / 371

页数：15

共 26 条

[1] THE KINETICS OF X-RAY SURVIVAL OF MAMMALIAN CELLS INVITRO [J].

BENDER, MA ;

GOOCH, PC .

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY AND RELATED STUDIES IN PHYSICS CHEMISTRY AND MEDICINE, 1962, 5 (02) :133-145

[2] CLONAL ORIGIN OF HUMAN-TUMORS [J].

FIALKOW, PJ .

ANNUAL REVIEW OF MEDICINE, 1979, 30 :135-143

[3] ON A POSSIBLE EPIGENETIC MECHANISM(S) OF TUMOR-CELL HETEROGENEITY - THE ROLE OF DNA METHYLATION [J].

FROST, P ;

KERBEL, RS .

CANCER AND METASTASIS REVIEWS, 1983, 2 (04) :375-378

[4] THE IMPLICATIONS OF TUMOR HETEROGENEITY FOR STUDIES ON THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].

HART, IR ;

FIDLER, IJ .

BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 651 (01) :37-50

[5] ANTIMETASTATIC DRUGS - LABORATORY TO CLINIC [J].

HELLMANN, K .

CLINICAL & EXPERIMENTAL METASTASIS, 1984, 2 (01) :1-4

[6] TUMOR HETEROGENEITY - BIOLOGICAL IMPLICATIONS AND THERAPEUTIC CONSEQUENCES [J].

HEPPNER, GH ;

MILLER, BE .

CANCER AND METASTASIS REVIEWS, 1983, 2 (01) :5-23

[7]

MINER KM, 1982, CANCER RES, V42, P4631

[8]

NERI A, 1981, INT J CANCER, V28, P731, DOI 10.1002/ijc.2910280612

[9]

NERI A, 1982, J NATL CANCER I, V68, P507

[10]

Nicolson G L, 1983, Curr Probl Cancer, V7, P1, DOI 10.1016/S0147-0272(83)80005-1

← 1 2 3 →